Diagnostic performance of an enzyme-linked immunospot assay for interferon-γ in skeletal tuberculosis.
The aim of this study was to evaluate the diagnostic performance of an enzyme-linked immunospot (ELISPOT) assay for interferon-γ in patients with suspected skeletal tuberculosis (TB). From March 2007 to June 2010, a total of 36 patients with suspected skeletal TB in a tertiary care hospital in Taiwan were enrolled. Twelve patients (35.3%) had culture-confirmed TB, three (8.8%) patients had probable TB, and the remaining 21 (58.3%) patients did not have TB. Fourteen patients with mycobacterial infection had available biopsy or surgical specimens for histopathological examination and 12 (85.7%) specimens had pathological features consistent with mycobacterial infection. Among the 12 patients with positive findings indicating mycobacterial infection, all seven patients with spinal TB and three of five patients with TB arthritis had positive ELISPOT assays. All nine patients with spinal TB had positive ELISPOT assays, but only four of six patients with TB arthritis had positive ELISPOT assays. The sensitivity, specificity, positive predictive value, and negative predictive value for skeletal TB diagnosis by the ELISPOT assay were 86.7%, 61.9%, 61.9%, and 86.7%, respectively. In conclusion, the ELISPOT assay can provide useful support in diagnosing skeletal TB, and spinal TB can be excluded based on a negative ELISPOT assay.
Department of Intensive Care Medicine, Chi-Mei Medical Center, Liouying, Tainan, Taiwan.
C-C
CC
Lai
C-K
CK
Tan
W-L
WL
Liu
S-H
SH
Lin
Y-T
YT
Huang
C-H
CH
Liao
P-R
PR
Hsueh
D000328:Adult; D000368:Aged; D019411:Clinical Laboratory Techniques / Q000379:methods*; D058501:Enzyme-Linked Immunospot Assay / Q000379:methods*; D005260:Female; D006651:Histocytochemistry; D006761:Hospitals; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013624:Taiwan; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology
D007371:Interferon-gamma
Am J Respir Crit Care Med. 2001 Mar;163(4):824-8
11282752
Chest. 2007 Sep;132(3):959-65
17505029
J Bone Joint Surg Am. 1996 Feb;78(2):288-98
8609123
J Infect. 2010 Sep;61(3):228-34
20600294
Clin Infect Dis. 2008 Oct 1;47(7):e57-63
18715157
J Infect. 2009 Dec;59(6):402-8
19819258
Int J Tuberc Lung Dis. 2008 Jun;12(6):651-7
18492332
Am J Gastroenterol. 2009 Aug;104(8):2121-2
19661948
Clin Microbiol Infect. 2009 Feb;15(2):173-9
19154487
Am Rev Respir Dis. 1990 Feb;141(2):347-51
2301852
Infection. 2008 Dec;36(6):601-4
18854935
Am J Med. 2009 Feb;122(2):189-95
19185094
Medicine (Baltimore). 1999 Sep;78(5):309-20
10499072
Lancet Infect Dis. 2004 Dec;4(12):761-76
15567126
Emerg Infect Dis. 2010 Feb;16(2):294-6
20113563
Am J Med. 2009 Aug;122(8):e3; author reply e5-6
19635262
J Infect Dis. 2002 Dec 15;186(12):1797-807
12447766
J Infect. 2006 Feb;52(2):77-85
16216328
Arch Intern Med. 2007 Nov 12;167(20):2255-9
17998500